{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/43357"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/43357","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"The role of the CACNA1A gene in the pathogenesis of episodic ataxia 2 and spinocerebellar ataxia 6","abstract":"CACNA1A encodes for the voltage-gated calcium channel CaV2.1. Mutations to CACNA1A are known to cause an assortment of disorders, including episodic ataxia 2, spinocerebellar ataxia 6, familial hemiplegic migraine 1, and more. The pathogenic nature behind these mutations is still unknown, but recent studies have given new information that points toward certain conclusions. In particular, episodic ataxia 2 appears to be caused (in some mutations) by misfolding and improper trafficking of both wild-type and mutant CaV2.1 channels. Spinocerebellar ataxia 6 is more complicated, as recent findings of the bicistronic nature of CACNA1A may mean that the disorder is more akin to a polyglutamine disease than a channelopathy. The goal of this thesis is to review the literature available that addresses these disorders and their progression, as well as future treatment strategies.","abstract_html":"CACNA1A encodes for the voltage-gated calcium channel CaV2.1. Mutations to CACNA1A are known to cause an assortment of disorders, including episodic ataxia 2, spinocerebellar ataxia 6, familial hemiplegic migraine 1, and more. The pathogenic nature behind these mutations is still unknown, but recent studies have given new information that points toward certain conclusions. In particular, episodic ataxia 2 appears to be caused (in some mutations) by misfolding and improper trafficking of both wild-type and mutant CaV2.1 channels. Spinocerebellar ataxia 6 is more complicated, as recent findings of the bicistronic nature of CACNA1A may mean that the disorder is more akin to a polyglutamine disease than a channelopathy. The goal of this thesis is to review the literature available that addresses these disorders and their progression, as well as future treatment strategies.","abstract_has_math":false,"creators":["Fabiano, Fredric"],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Medical Sciences","degree_department":null,"school":null,"contributors":[],"advisors":["Garcia-Diaz, J. Fernando"],"committee_chairs":[],"committee_members":[],"year":2021,"date_issued":"2021","date_published":"2021","updated_at":"2026-11-18T19:45:25Z","subjects":["Molecular biology"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/43357","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/43357","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F43357","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Garcia-Diaz, J. Fernando"]},{"key":"dc:creator","label":"Author","values":["Fabiano, Fredric"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2021-11-17T14:58:15Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2021-11-17T14:58:15Z"]},{"key":"dc:date.issued","label":"Date","values":["2021"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2021-11-11T02:03:03Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Molecular biology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/43357"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["CACNA1A encodes for the voltage-gated calcium channel CaV2.1. Mutations to CACNA1A are known to cause an assortment of disorders, including episodic ataxia 2, spinocerebellar ataxia 6, familial hemiplegic migraine 1, and more. The pathogenic nature behind these mutations is still unknown, but recent studies have given new information that points toward certain conclusions. In particular, episodic ataxia 2 appears to be caused (in some mutations) by misfolding and improper trafficking of both wild-type and mutant CaV2.1 channels. Spinocerebellar ataxia 6 is more complicated, as recent findings of the bicistronic nature of CACNA1A may mean that the disorder is more akin to a polyglutamine disease than a channelopathy. The goal of this thesis is to review the literature available that addresses these disorders and their progression, as well as future treatment strategies."]},{"key":"dc:title","label":"Title","values":["The role of the CACNA1A gene in the pathogenesis of episodic ataxia 2 and spinocerebellar ataxia 6"]}]}],"canonical_facts":{"dc:contributor.advisor":["Garcia-Diaz, J. Fernando"],"dc:creator":["Fabiano, Fredric"],"dc:date.accessioned":["2021-11-17T14:58:15Z"],"dc:date.available":["2021-11-17T14:58:15Z"],"dc:date.issued":["2021"],"dc:date.updated":["2021-11-11T02:03:03Z"],"dc:description.abstract":["CACNA1A encodes for the voltage-gated calcium channel CaV2.1. Mutations to CACNA1A are known to cause an assortment of disorders, including episodic ataxia 2, spinocerebellar ataxia 6, familial hemiplegic migraine 1, and more. The pathogenic nature behind these mutations is still unknown, but recent studies have given new information that points toward certain conclusions. In particular, episodic ataxia 2 appears to be caused (in some mutations) by misfolding and improper trafficking of both wild-type and mutant CaV2.1 channels. Spinocerebellar ataxia 6 is more complicated, as recent findings of the bicistronic nature of CACNA1A may mean that the disorder is more akin to a polyglutamine disease than a channelopathy. The goal of this thesis is to review the literature available that addresses these disorders and their progression, as well as future treatment strategies."],"dc:identifier.uri":["https://hdl.handle.net/2144/43357"],"dc:language.iso":["en_US"],"dc:subject":["Molecular biology"],"dc:title":["The role of the CACNA1A gene in the pathogenesis of episodic ataxia 2 and spinocerebellar ataxia 6"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Medical Sciences"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-18T19:45:25Z"}